Skip to main content

Functional Orthogonality of Parvoviral Phospholipase A2 (PLA2) Domains in Recombinant AAV Vector Transduction

Publication ,  Conference
Hull, J; Fusco, R; Tan, J; Ochoa, M; Wan, X; Hall, A; Asokan, A
Published in: MOLECULAR THERAPY
2025

Duke Scholars

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

2025

Volume

33

Issue

4

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hull, J., Fusco, R., Tan, J., Ochoa, M., Wan, X., Hall, A., & Asokan, A. (2025). Functional Orthogonality of Parvoviral Phospholipase A2 (PLA2) Domains in Recombinant AAV Vector Transduction. In MOLECULAR THERAPY (Vol. 33).
Hull, Joshua, Robert Fusco, Jeffery Tan, Mark Ochoa, Xinlong Wan, Aaron Hall, and Aravind Asokan. “Functional Orthogonality of Parvoviral Phospholipase A2 (PLA2) Domains in Recombinant AAV Vector Transduction.” In MOLECULAR THERAPY, Vol. 33, 2025.
Hull J, Fusco R, Tan J, Ochoa M, Wan X, Hall A, et al. Functional Orthogonality of Parvoviral Phospholipase A2 (PLA2) Domains in Recombinant AAV Vector Transduction. In: MOLECULAR THERAPY. 2025.
Hull J, Fusco R, Tan J, Ochoa M, Wan X, Hall A, Asokan A. Functional Orthogonality of Parvoviral Phospholipase A2 (PLA2) Domains in Recombinant AAV Vector Transduction. MOLECULAR THERAPY. 2025.

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

2025

Volume

33

Issue

4

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences